Related Experiment Videos
Compound profiling for P-glycoprotein at the blood-brain barrier using a microplate screening system
Björn Bauer1, David S Miller, Gert Fricker
1Institute of Pharmacy and Molecular Biotechnology, University of Heidelberg, INF 366 69120 Heidelberg, Germany.
Pharmaceutical Research
|September 2, 2003
Summary
A new assay using calcein-acetoxymethylester (calcein-AM) and porcine brain capillary endothelial cells (PBCECs) can rapidly screen drug interactions with p-glycoprotein (P-gp) at the blood-brain barrier. This method also allows for kinetic analysis of these interactions.
Area of Science:
- Pharmacology
- Neuroscience
- Biochemistry
Background:
- P-glycoprotein (P-gp) is a key efflux transporter at the blood-brain barrier.
- Understanding drug interactions with P-gp is crucial for predicting drug efficacy and CNS penetration.
- Existing methods for P-gp interaction screening can be time-consuming and complex.
Purpose of the Study:
- To develop a rapid, fluorescent dye-based assay for screening compound interactions with P-gp.
- To evaluate the utility of this assay for kinetic analysis of P-gp transport.
- To utilize porcine brain capillary endothelial cells (PBCECs) for P-gp studies.
Main Methods:
- Isolated PBCECs were cultured in 96-well plates.
- Cells were incubated with calcein-acetoxymethylester (calcein-AM) in the presence of various ABC transporter substrates and inhibitors.
- Intracellular fluorescence was measured using a fluorescence plate reader to assess calcein-AM efflux.
Main Results:
- PBCECs demonstrated stable P-gp expression, leading to calcein-AM extrusion.
- P-gp substrates and inhibitors significantly increased intracellular fluorescence, indicating reduced calcein-AM efflux.
- The observed increase in fluorescence correlated with the P-gp affinity of the tested compounds.
- Kinetic analysis revealed competitive, mixed, and non-competitive inhibition patterns.
Conclusions:
- The calcein-AM assay using PBCECs is a viable microplate screening system for drug-P-gp interactions at the blood-brain barrier.
- This assay serves as a valuable tool for drug profiling and understanding drug interactions.
- The assay facilitates convenient kinetic studies to elucidate the mode of P-gp inhibition.